Martin Christopher Nathan
Reporting Owner SEC Filing List
CIK: 0002097992
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Edgewise Therapeutics, Inc. | 06/16/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Martin Christopher Nathan | 06/16/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Oruka Therapeutics, Inc. | 06/03/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Martin Christopher Nathan | 06/03/2026 | ||||
| 3 | Initial statement of beneficial ownershi... | Achieve Life Sciences, Inc. | Donnelley Financial Solutions /fa/ | 05/13/2026 | |||
| 4 | Statement of changes in beneficial owner... | Achieve Life Sciences, Inc. | Donnelley Financial Solutions /fa/ | 05/13/2026 | |||
| 3 | Initial statement of beneficial ownershi... | Martin Christopher Nathan | 05/13/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Martin Christopher Nathan | 05/13/2026 | ||||
| 3 | Initial statement of beneficial ownershi... | Oruka Therapeutics, Inc. | 12/11/2025 | ||||
| 4 | Statement of changes in beneficial owner... | Oruka Therapeutics, Inc. | 12/11/2025 | ||||
| Load More | |||||||
Martin Christopher Nathan 's Ownership Transactions
| Issuer | Filing Date | Transaction Date | Transaction Type | Shares | Price | Total Amt | Shares Owned |
|---|
